PL372993A1 - Zastosowanie specyficznej pochodnej aminy cyklicznej lub jej farmaceutycznie dopuszczalnych soli doleczenia lub zapobiegania niewydolności serca - Google Patents

Zastosowanie specyficznej pochodnej aminy cyklicznej lub jej farmaceutycznie dopuszczalnych soli doleczenia lub zapobiegania niewydolności serca

Info

Publication number: PL372993A1
Authority: PL; Poland
Prior art keywords: prevention; treatment; pharmaceutically acceptable; acceptable salts; heart failure
Prior art date: 2002-07-25

Application number

PL03372993A

Other languages

English (en)

Other versions

PL214716B1 (pl

Inventor

Brian Guth

Juergen Daemmgen

Randolph Seidler

Original Assignee

Boehringer Ingelheim Pharma Gmbh & Co.Kg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-25

Filing date

2003-07-21

Publication date

2005-08-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29265956&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL372993(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-07-21 Application filed by Boehringer Ingelheim Pharma Gmbh & Co.Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co.Kg

2005-08-08 Publication of PL372993A1 publication Critical patent/PL372993A1/pl

2013-09-30 Publication of PL214716B1 publication Critical patent/PL214716B1/pl

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Cardiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL372993A 2002-07-25 2003-07-21 Zastosowanie cilobradyny lub jej farmaceutycznie dopuszczalnej soli do wytwarzania kompozycji farmaceutycznej do leczenia lub zapobiegania niewydolnosci serca PL214716B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP02016602A EP1362590B1 (en)	2002-07-25	2002-07-25	Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure

Publications (2)

Publication Number	Publication Date
PL372993A1 true PL372993A1 (pl)	2005-08-08
PL214716B1 PL214716B1 (pl)	2013-09-30

Family

ID=29265956

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL372993A PL214716B1 (pl)	2002-07-25	2003-07-21	Zastosowanie cilobradyny lub jej farmaceutycznie dopuszczalnej soli do wytwarzania kompozycji farmaceutycznej do leczenia lub zapobiegania niewydolnosci serca

Country Status (29)

Country	Link
US (1)	US20130317008A1 (pl)
EP (2)	EP1362590B1 (pl)
JP (3)	JP2005533853A (pl)
KR (1)	KR20050074432A (pl)
CN (1)	CN100502874C (pl)
AR (1)	AR040690A1 (pl)
AT (2)	ATE257384T1 (pl)
AU (1)	AU2003254554B8 (pl)
BR (1)	BR0312852A (pl)
CA (1)	CA2493208C (pl)
CO (1)	CO5700723A2 (pl)
CY (1)	CY1112173T1 (pl)
DE (1)	DE60200160T2 (pl)
DK (2)	DK1362590T3 (pl)
ES (2)	ES2211846T3 (pl)
HR (1)	HRP20050075B1 (pl)
MX (1)	MXPA05000617A (pl)
MY (1)	MY128529A (pl)
NZ (1)	NZ538424A (pl)
PE (1)	PE20040706A1 (pl)
PL (1)	PL214716B1 (pl)
PT (2)	PT1362590E (pl)
SA (1)	SA03240350B1 (pl)
SI (2)	SI1362590T1 (pl)
TR (1)	TR200400127T4 (pl)
TW (1)	TWI319321B (pl)
UY (1)	UY27910A1 (pl)
WO (1)	WO2004011006A1 (pl)
ZA (1)	ZA200500084B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1362590B1 (en) *	2002-07-25	2004-01-07	Boehringer Ingelheim Pharma GmbH & Co.KG	Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
US20040138306A1 (en)	2002-07-25	2004-07-15	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
JPWO2007023775A1 (ja) *	2005-08-23	2009-02-26	アステラス製薬株式会社	心房細動治療剤
EP1762179A1 (en)	2005-09-07	2007-03-14	Boehringer Ingelheim Vetmedica Gmbh	Method for improving diagnostic quality in echocardiography
FR2894825B1 (fr) *	2005-12-21	2010-12-03	Servier Lab	Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2927538B1 (fr)	2008-02-14	2010-02-19	Servier Lab	Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.
FR2961105B1 (fr) *	2010-06-15	2013-02-08	Servier Lab	Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
WO2013024036A1 (en)	2011-08-12	2013-02-21	Boehringer Ingelheim Vetmedica Gmbh	Funny current (if) inhibitors for use in a method of treating and preventing heart failure in feline
WO2014122248A1 (en)	2013-02-11	2014-08-14	Boehringer Ingelheim Vetmedica Gmbh	Kit-of-parts

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3541811A1 (de) *	1985-11-27	1987-06-04	Thomae Gmbh Dr K	Neue cyclische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5175157A (en) *	1985-11-27	1992-12-29	Boehringer Ingelheim Gmbh	Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them
DE3736866A1 (de) *	1987-10-30	1989-05-11	Thomae Gmbh Dr K	Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz
DE3805635A1 (de) *	1988-02-24	1989-09-07	Thomae Gmbh Dr K	Verwendung von benzimidazolen zur herstellung eines arzneimittels mit antiischaemischen wirkungen am herzen und dessen kombinationen mit ss-blockern oder bradycardica
US5760069A (en) *	1995-02-08	1998-06-02	Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1	Method of treatment for decreasing mortality resulting from congestive heart failure
JP4240173B2 (ja) *	1998-06-03	2009-03-18	日産化学工業株式会社	インダン誘導体
DE60009287T2 (de) *	1999-06-03	2005-02-17	Yamanouchi Pharmaceutical Co., Ltd.	Neuartige isoquinolin-derivate oder salze davon
DE10018401A1 (de) *	2000-04-13	2001-10-25	Boehringer Ingelheim Pharma	Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
EP1362590B1 (en) *	2002-07-25	2004-01-07	Boehringer Ingelheim Pharma GmbH & Co.KG	Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure

2002
- 2002-07-25 EP EP02016602A patent/EP1362590B1/en not_active Expired - Lifetime
- 2002-07-25 DK DK02016602T patent/DK1362590T3/da active
- 2002-07-25 TR TR2004/00127T patent/TR200400127T4/xx unknown
- 2002-07-25 DE DE60200160T patent/DE60200160T2/de not_active Expired - Lifetime
- 2002-07-25 SI SI200230008T patent/SI1362590T1/xx unknown
- 2002-07-25 ES ES02016602T patent/ES2211846T3/es not_active Expired - Lifetime
- 2002-07-25 AT AT02016602T patent/ATE257384T1/de active
- 2002-07-25 PT PT02016602T patent/PT1362590E/pt unknown
2003
- 2003-07-21 AU AU2003254554A patent/AU2003254554B8/en not_active Ceased
- 2003-07-21 ES ES03771064T patent/ES2367109T3/es not_active Expired - Lifetime
- 2003-07-21 PL PL372993A patent/PL214716B1/pl unknown
- 2003-07-21 CA CA2493208A patent/CA2493208C/en not_active Expired - Fee Related
- 2003-07-21 NZ NZ538424A patent/NZ538424A/en not_active IP Right Cessation
- 2003-07-21 SI SI200332021T patent/SI1534296T1/sl unknown
- 2003-07-21 JP JP2004523757A patent/JP2005533853A/ja active Pending
- 2003-07-21 HR HRP20050075AA patent/HRP20050075B1/hr not_active IP Right Cessation
- 2003-07-21 MX MXPA05000617A patent/MXPA05000617A/es active IP Right Grant
- 2003-07-21 PT PT03771064T patent/PT1534296E/pt unknown
- 2003-07-21 BR BR0312852-0A patent/BR0312852A/pt not_active Application Discontinuation
- 2003-07-21 EP EP03771064A patent/EP1534296B1/en not_active Expired - Lifetime
- 2003-07-21 AT AT03771064T patent/ATE510543T1/de active
- 2003-07-21 CN CNB03817829XA patent/CN100502874C/zh not_active Expired - Fee Related
- 2003-07-21 WO PCT/EP2003/007929 patent/WO2004011006A1/en not_active Ceased
- 2003-07-21 KR KR1020057001298A patent/KR20050074432A/ko not_active Ceased
- 2003-07-21 DK DK03771064.7T patent/DK1534296T3/da active
- 2003-07-23 MY MYPI20032768A patent/MY128529A/en unknown
- 2003-07-24 PE PE2003000735A patent/PE20040706A1/es not_active Application Discontinuation
- 2003-07-24 TW TW092120260A patent/TWI319321B/zh not_active IP Right Cessation
- 2003-07-25 AR AR20030102678A patent/AR040690A1/es not_active Application Discontinuation
- 2003-07-31 UY UY27910A patent/UY27910A1/es not_active Application Discontinuation
- 2003-10-19 SA SA03240350A patent/SA03240350B1/ar unknown
2005
- 2005-01-05 ZA ZA2005/00084A patent/ZA200500084B/en unknown
- 2005-02-24 CO CO05017675A patent/CO5700723A2/es not_active Application Discontinuation
2009
- 2009-08-06 JP JP2009183392A patent/JP2009256379A/ja active Pending
2011
- 2011-08-24 CY CY20111100812T patent/CY1112173T1/el unknown
2013
- 2013-05-21 JP JP2013107160A patent/JP2013166781A/ja active Pending
- 2013-08-01 US US13/956,918 patent/US20130317008A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN1671392A (zh)	2005-09-21
EP1534296A1 (en)	2005-06-01
ES2211846T3 (es)	2004-07-16
DK1534296T3 (da)	2011-08-15
CO5700723A2 (es)	2006-11-30
NZ538424A (en)	2006-10-27
WO2004011006A1 (en)	2004-02-05
AU2003254554A1 (en)	2004-02-16
JP2005533853A (ja)	2005-11-10
BR0312852A (pt)	2005-04-19
CA2493208C (en)	2011-11-01
SA03240350B1 (ar)	2007-10-29
UY27910A1 (es)	2004-02-27
CN100502874C (zh)	2009-06-24
TR200400127T4 (tr)	2004-02-23
TWI319321B (en)	2010-01-11
DE60200160T2 (de)	2004-11-04
HRP20050075B1 (hr)	2013-12-20
EP1362590A1 (en)	2003-11-19
KR20050074432A (ko)	2005-07-18
AU2003254554B8 (en)	2009-02-26
TW200412974A (en)	2004-08-01
SI1534296T1 (sl)	2011-09-30
SI1362590T1 (sl)	2004-04-30
MXPA05000617A (es)	2005-08-19
US20130317008A1 (en)	2013-11-28
JP2009256379A (ja)	2009-11-05
PT1362590E (pt)	2004-05-31
HRP20050075A2 (en)	2005-12-31
EP1362590B1 (en)	2004-01-07
ZA200500084B (en)	2005-10-26
AR040690A1 (es)	2005-04-13
PE20040706A1 (es)	2004-12-06
ES2367109T3 (es)	2011-10-28
ATE510543T1 (de)	2011-06-15
DE60200160D1 (de)	2004-02-12
CA2493208A1 (en)	2004-02-05
JP2013166781A (ja)	2013-08-29
DK1362590T3 (da)	2004-03-29
CY1112173T1 (el)	2015-12-09
AU2003254554B2 (en)	2009-01-29
EP1534296B1 (en)	2011-05-25
EP1362590A8 (en)	2004-02-25
PL214716B1 (pl)	2013-09-30
MY128529A (en)	2007-02-28
ATE257384T1 (de)	2004-01-15
PT1534296E (pt)	2011-08-18

Publication	Publication Date	Title
PL375964A1 (pl)	2005-12-12	Zastosowanie pochodnych indolilu do wytwarzania leku do leczenia kataru siennego
DE60329001D1 (en)	2009-10-08	8-hydroxychinolinderivate
AU2003291992A1 (en)	2004-05-25	Phenylethanolamine derivatives for the treatment of respiratory diseases
AU2003257613A1 (en)	2004-03-11	Catheter for treating irregular heart pulse
PT1656346E (pt)	2009-05-20	Indole 1,2,3,4-tetrassubstituído para o tratamento de doenças respiratórias
IL213806A0 (en)	2011-07-31	Use of derivatives of n-phenylpiperazin-1-yl-acetamide for the preparation of a pharmaceutical compositions for treatment of diabetes related conditions
SI1578741T1 (sl)	2011-11-30	Aromatske spojine kot protivnetna imunomodulatorna in antiproliferativna sredstva
IL173145A (en)	2010-12-30	Use of a pak inhibitor for the production of a medicament for the treatment of a joint disease
TWI319321B (en)	2010-01-11	Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
WO2007126898A8 (en)	2008-04-03	Use of ladostigil for the treatment of schizophrenia
PL378537A1 (pl)	2006-05-02	Zastosowanie propionylo L-karnityny do otrzymywania leku do leczenia glaukomii
AU1522101A (en)	2001-05-30	Heparanase inhibitors for the treatment of heart failure
AU2003301758A8 (en)	2004-05-25	Use of pyrimidine derivates for the manifacture of a medicament for the treatment of hyper-proliferative disorders
EP1579867A4 (en)	2006-08-09	MEDICAL COMPOSITION FOR THE TREATMENT OF ISCHEMIC HEART FAILURE
WO2004035031A3 (en)	2004-07-15	Treatment of uveal melanoma
HRP20041159A2 (en)	2005-08-31	Combination for the treatment of airway disorders
AU2003269985A8 (en)	2004-03-11	Methods for increasing the rate of heart muscle contraction
SI1553938T1 (sl)	2007-06-30	Uporaba epotilonskih derivatov za zdravljenje hiperparatiroidizma
IL164388A0 (en)	2005-12-18	Use of ranolazine for the preparation of a medicament for the treatment of arrhymias
WO2003004019A8 (en)	2003-08-14	Use of heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic distamycin a for the treatment of beta-thalassaemia
SI1408977T1 (sl)	2005-12-31	Kombinacijska terapija za zdravljenje srcne insuficence
AU2002345140A1 (en)	2003-03-03	A combination therapy for the treatment of heart failure
GB0206708D0 (en)	2002-05-01	Pharmaceutical salts
GB0204683D0 (en)	2002-04-17	Pharmaceutical salts
GB0224328D0 (en)	2002-11-27	Combination therapy for respiratory disorders